BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 11111231)

  • 1. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile.
    Shev S; Widell A; Foberg U; Frydén A; Hermodsson S; Lindh G; Lindholm A; Månsson S; Weiland O; Norkrans G
    Infection; 1995; 23(5):253-7. PubMed ID: 8557380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso.
    Zeba MT; Sanou M; Bisseye C; Kiba A; Nagalo BM; Djigma FW; Compaoré TR; Nebié YK; Kienou K; Sagna T; Pietra V; Moret R; Simporé J
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s54-7. PubMed ID: 24599906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
    Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
    Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C infection and its associated factors in healthy adults without identifiable route of transmission.
    Wong NS; Lee CK; Ng SC; Wong HK; Chan DPC; Lee SS
    J Viral Hepat; 2018 Feb; 25(2):161-170. PubMed ID: 29032634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
    Lin H; Chen X; Zhu S; Mao P; Zhu S; Liu Y; Huang C; Sun J; Zhu J
    Intervirology; 2016; 59(4):204-210. PubMed ID: 28208127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute nosocomial HCV infection detected by NAT of a regular blood donor.
    Larke B; Hu YW; Krajden M; Scalia V; Byrne SK; Boychuk LR; Klein J
    Transfusion; 2002 Jun; 42(6):759-65. PubMed ID: 12147030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus genotypes in French blood donors.
    Gournay J; Marcellin P; Martinot-Peignoux M; Degott C; Gabriel F; Courtois F; Branger M; Wild AM; Erlinger S; Benhamou JP
    J Med Virol; 1995 Apr; 45(4):399-404. PubMed ID: 7545210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
    Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].
    Durand F; Danic B; Tardivel R; Semana G; Gouezec H; Martinot M; Marcellin P; Beauplet A
    Transfus Clin Biol; 2000 Jun; 7(3):242-50. PubMed ID: 10919211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group.
    Dubois F; Desenclos JC; Mariotte N; Goudeau A
    Hepatology; 1997 Jun; 25(6):1490-6. PubMed ID: 9185773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.
    Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H
    Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HCV genotypes in Polish blood donors in period 1995-2007].
    Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
    Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors.
    Thakral B; Marwaha N; Chawla YK; Saluja K; Sharma A; Sharma RR; Minz RW; Agnihotri SK
    Indian J Med Res; 2006 Oct; 124(4):431-8. PubMed ID: 17159264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.